Trials / Completed
CompletedNCT00334750
Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada
Distribution of Risk Factors Amongst Ocular Hypertension and Open-Angle Glaucoma Patients in Canada
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 410 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This descriptive, non-interventional study will collect information on the presence of risk factors in newly diagnosed ocular hypertension and open-angle glaucoma patients in Canada.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | There is no intervention in this study. | This study is collecting information on the presence of risk factors in new diagnosed OH and OAG patients in Canada. |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2006-06-08
- Last updated
- 2021-02-02
Locations
21 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00334750. Inclusion in this directory is not an endorsement.